Activated Attapulgite; Bismuth Subcarbonate; Kanamycin

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

2500.0%

Death Rate

Active Ingredients

Activated Attapulgite; Bismuth Subcarbonate; Kanamycin

Administration Routes

UnknownOral

Species Affected

Dog 8

Unknown 3

Cat 1

Most Affected Breeds

Unknown 3

Shepherd (unspecified) 3

Mixed (Dog) 2

Shepherd Dog - German 2

Terrier - Airedale 1

Cat (unknown) 1

Most Reported Reactions

Seizure NOS 3

Uncoded sign 2

Seal, Abnormal 2

Pulmonary oedema 2

Death 2

Suspension, Abnormal 1

Constipation 1

Caps, Abnormal 1

Loose stool 1

Hyperkeratosis 1

Alopecia local 1

Inappetence 1

Outcome Breakdown

Outcome Unknown

4 (40.0%)

Ongoing

2 (20.0%)

Died

2 (20.0%)

Recovered/Normal

1 (10.0%)

Euthanized

1 (10.0%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.